Der globale Markt für neuartige Arzneimittelabgabesysteme wird zwischen 2022 und 2031 um eine CAGR von ~8 % wachsen; Steigender Bedarf an gezielter medikamentöser Therapie zur Förderung des Marktwachstums

Research Nester has published a report titled “Novel Drug Delivery Systems Market: Global Demand Analysis & Opportunity Outlook 2031,” which provides a detailed overview of global novel drug delivery systems in terms of market segmentation by delivery type, end user, and region.
In addition, for in-depth analysis, the report includes the industry growth indicators, restraints, supply and demand risks, and a detailed discussion of current and future market trends associated with the growth of the market.
For more information, see https://www.researchnester.com/reports/novel-drug-delivery-systems-market/3930
The global market for novel drug delivery systems is expected to grow at a CAGR of ~8% during the forecast period, i.e. 2022 – 2031. Transdermal drug delivery, implantable drug delivery, and others where the implantable drug delivery segment is expected to hold a significant revenue share during the forecast period. This may be attributed to the use of implantable drugs to treat complex problems such as cancer treatment, contraception, hormone regulation, and others.
The global market for novel drug delivery systems is expected to grow due to the demand for more controlled targeted release of drugs, especially for the treatment of cancer cells. In addition, it is estimated that the increasing prevalence of cancer will further boost the market growth. According to the World Health Organization (WHO), 10 million deaths were caused by cancer in 2020. In addition, it is estimated that rising global healthcare expenditures combined with growing investment in R&D activities are driving the market growth.
Based on geographic analysis, the global market for novel drug delivery systems is divided into five main regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa region. The market in the North America region is expected to gain the largest market share throughout the forecast period due to increasing healthcare research activities, high healthcare expenditures and adoption of advanced technologies in the region.
The research is global in nature and includes detailed market analyses in North America (USA, Canada), Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands and Luxembourg), NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of the Asia Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of the Middle East and Africa). In addition, an analysis that includes market size, Y-O-Y growth and opportunity analysis, competitive study of market participants, investment opportunities, demand for future prospects, etc. was also covered and displayed in the research report.
Growing demand for foProgressive targeted drug delivery to promote market growth
Targeted drug therapy is one of the most common treatment approaches to treat cancer growth. It is estimated that the increasing implementation of targeted drug delivery for cancer treatment will boost the market growth. In addition, the globally escalating cancer cases are expected to continue to drive the market growth.
However, increasing adoption of generics is expected to severely constrain the growth of global novel drug delivery systems during the forecast period.
This report also includes the existing competitive scenario of some of the key players in the global novel drug delivery systems, including company profiles of Mylan N.V., Novartis International AG, Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Teva Pharmaceutical Industries Ltd. and Antares Pharma, Inc. Profiling includes key information from the companies, which includes a business overview, products and services, key financial data, and the latest news and developments. Overall, the report provides a detailed overview of the global novel drug delivery systems that will help industry consultants, device manufacturers, existing players looking for expansion opportunities, new players looking for opportunities, and other stakeholders align their market-driven strategies with current and anticipated trends in the future.
Sample Report anfordern@ https://www.researchnester.com/sample-request-3930
Research Nester is a leading provider of strategic market research and consulting. Our goal is to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives make smart decisions for their future marketing strategy, expansion and investment, etc. We believe that every company can broaden its new horizons, provided that strategic minds provide the right guidance at the right time. Our out-of-box thinking helps our clients make smart decisions to avoid future uncertainty.
Contact for further information:AJ Daniel
Email: info@researchnester.com
US Phone: +1 646 586 9123
United Kingdom Phone:
+44 203 608 5919